Synaptogenix

1 follower


Discovering restorative, novel therapeutics for patients with life altering neurodegenerative diseases and developmental disorders.

Industries

Employees

Links

Org chart

Alan Tuchman
Chief Executive Officer

Alan Tuchman

Collapse
Daniel L. Alkon
President & Chief Science Officer
Robert Weinstein
Chief Financial Officer
Elaine Grenier
Executive Director, Clinical Ops